Week 8 Drug Quiz

3-10 units IM following delivery of the placenta; 10-20 U in 1,000 mL of D5W or NS IV infusion titrated to the severity of the bleeding.

1.5-2.0 g/kg slow IV infusion

1-3 mg slow IV (over 2-5minutes), not to exceed 1mg/min. May repeat dose in 2minutes to total dose of 0.1 mg/kg.

50-100 mg IV or IM

15 mg IV, then 0.75 mg/kg (up to 50mg) over 30minutes, then 0.5 mg/kg (up to 35mg) over 60minutes.

4mg IV

Decreases cellular edema, increases urinary output.

Causes uterine contractions, slows postpartum vaginal bleeding, causes lactation.

Blocks stimulation of beta1 and beta2 adrenergic receptor sites.

Allows normal breakdown of glucose.

Converts plasminogen to plasmin.

Serotonin receptor antagonist.

Nausea/Vomiting.

AMI, acute ischemis stroke.

Coma of unknown origin, alcoholism, delirium tremens.

Acute cerebral edema, blood transfusion reactions.

HTN, angina, arrhythmias, pheochromocytoma.

Postpartum vaginal bleeding.

Any condition other than postpartum vaginal bleeding.

Uncompensated CHF, pulmonary edema, cardiogenic shock, bradycardia, heart blocks.

Pulmonary edema, dehydration, hypersensitivity.

Hypersensitivity.

S/S of bleeding, stoke within last 6months, recent intracranial/spinal surgery or trauma, uncontrolled HTN.

Hypersensitivity.

Diarrhea, HA, fever, constipation.

Allergic reaction, phlebitis, bleeding, reperfusion, arrhythmias.

Angioedema, paresthesias, rash, anaphylaxis with rapid IVP.

Transient volume expansion, confusion, CHF, headache, pulmonary edema, tachycardia.

Fatigue, weakness, bronchospasm, bradycardia, CHF, pulmonary edema, hypotension, hypo/hyperglycemia.

Anaphylaxis, cardiac arrhythmias, H2O intoxication.